PAI-1 is the chief inhibitor of fibrinolysis that has been strongly associated with thrombosis, obesity, dyslipidemia, insulin resistance, and premature aging, which are parallel circumstances in COPD, but also with the extra-pulmonary manifestations in COPD [36]. The gene discussed is SERPINE1; the disease is Insulin resistance.